Microtubule inhibitor-based antibody–drug conjugates for cancer therapy
Kelsey Klute,1,* Eleni Nackos,1,* Shinsuke Tasaki,1 Daniel P Nguyen,2 Neil H Bander,2 Scott T Tagawa1,2 1Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA; 2Department of Urology, Weill Cornell Medical College, New York, NY, USA *T...
Main Authors: | Klute K, Nackos E, Tasaki S, Nguyen DP, Bander NH, Tagawa ST |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-12-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/microtubule-inhibitor-based-antibodyndashdrug-conjugates-for-cancer-th-peer-reviewed-article-OTT |
Similar Items
Similar Items
-
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
by: Hao Chen, et al.
Published: (2017-08-01) -
Antibody–Drug Conjugates for Cancer Therapy
by: Umbreen Hafeez, et al.
Published: (2020-10-01) -
Antibody Drug Conjugates for Cancer Therapy
by: S M Gheibi hayat, et al.
Published: (2017-07-01) -
Antibody–Drug Conjugates for Cancer Therapy
by: Adam C. Parslow, et al.
Published: (2016-07-01) -
Potential of antibody–drug conjugates and novel therapeutics in breast cancer management
by: Lianos GD, et al.
Published: (2014-03-01)